Antimicrobial · Antimicrobial peptide (AMP) reference standard · MCDP-003
Mast Cell Degranulating Peptide
- Drug class
- Antimicrobial peptide (AMP) reference standard
- Status
- Research use only
- Catalog code
- MCDP-003
- Also known as
- MCDP-003
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What Mast Cell Degranulating Peptide is studied for
- Minimum inhibitory concentration (MIC) screens against Gram-positive and Gram-negative panels
- Biofilm disruption and anti-biofilm surface coatings
- Structure–activity relationship (SAR) studies for AMP analogues
- Host-defense and innate-immunity mechanistic work
Mechanism of action
Mast Cell Degranulating Peptide sits within the Antimicrobial research class (CPC reference MCDP-003). Antimicrobial peptides typically disrupt bacterial, fungal, or viral membranes through direct electrostatic and hydrophobic interactions, or by triggering intracellular targets after translocation. Assay potency is usually reported as MIC (minimum inhibitory concentration) against reference strains. Investigators typically incorporate Mast Cell Degranulating Peptide as a reference standard, tool ligand, or substrate in the assay contexts listed above. Most commonly used in broth microdilution MIC assays (CLSI M07), radial diffusion assays, and membrane-permeabilization (SYTOX / DiSC₃-5) readouts.
Frequently asked questions
What is Mast Cell Degranulating Peptide?
Mast Cell Degranulating Peptide (CPC catalog code MCDP-003) is a synthetic antimicrobial peptide (amp) reference standard in the antimicrobial category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
What is Mast Cell Degranulating Peptide studied for?
Published and internal research programs use Mast Cell Degranulating Peptide as a reference standard in antimicrobial workflows — for example, minimum inhibitory concentration (mic) screens against gram-positive and gram-negative panels and biofilm disruption and anti-biofilm surface coatings. Human clinical evidence is not established.
Is Mast Cell Degranulating Peptide FDA-approved for human use?
No. Mast Cell Degranulating Peptide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
How is Mast Cell Degranulating Peptide typically used in the lab?
In a antimicrobial workflow, Mast Cell Degranulating Peptide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Most commonly used in broth microdilution MIC assays (CLSI M07), radial diffusion assays, and membrane-permeabilization (SYTOX / DiSC₃-5) readouts.
How should Mast Cell Degranulating Peptide be stored?
Lyophilized peptide is stable long-term at −20 °C. Reconstituted stock solutions are typically stored at 4 °C for short-term use or aliquoted and frozen for longer storage. Follow your institution's standard operating procedures for handling synthetic peptides.
Where does the Mast Cell Degranulating Peptide product page point to?
This kindr reference page mirrors CPC Scientific's catalog metadata for MCDP-003. The upstream reference sheet — including sequence, purity, MW, and application notes where published — is linked from the buy panel. All orders placed on kindr Peptides ship internationally under research-use terms only.
What quality specifications apply to Mast Cell Degranulating Peptide?
Research-grade peptides in the CPC catalog are synthesized by solid-phase peptide synthesis (SPPS), purified by preparative RP-HPLC, and characterized by analytical HPLC and mass spectrometry. Typical purity is ≥95%; certificate of analysis is available on request.
Related peptides in Antimicrobial
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal
